STAT3 and osteosarcoma: LIF promotes the stem cell properties of osteosarcoma through the NOTCH1 signaling pathway [50] and enhances the growth and invasion of osteosarcoma by activating STAT3 signaling, while blocking STAT3 signaling can inhibit the development of osteosarcoma [51].